PharmaShots | Incisive News in 3 Shots

Subscribe Now

High bleeding risk

Abbott's XIENCE Stent Receives the US FDA's Approval for Shortest Blood Thinner Course in Patients with High Bleeding Risk

Abbott's XIENCE Stent Receives the US FDA's Approval for Shortest Blood Thinner Course in Patients with High Bleeding Risk

July 1, 2021

Medtronic Reports Results of Resolute Onyx DES in Onyx ONE Global Study for High-Bleeding Risk Patients with One-Month DAPT

Medtronic Reports Results of Resolute Onyx DES in Onyx ONE Global Study for High-Bleeding Risk Patients with One-Month DAPT

September 27, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us